A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Overactive BladderPharmacokinetics
Interventions
DRUG

warfarin

Oral

DRUG

YM178

Oral

Trial Locations (1)

75015

Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00856570 - A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects | Biotech Hunter | Biotech Hunter